Oestrogen receptive positive breast cancer can be treated by drugs, such as fulvestrant, that interfere with the action of oestrogen.

stay healthy…
Oestrogen receptive positive breast cancer can be treated by drugs, such as fulvestrant, that interfere with the action of oestrogen.
According to the Mayo Clinic, about 20% of breast cancers make abnormally high levels of a protein called human epidermal
In 2009, disagreement in the health community arose following a recommendation from the United States Preventive Services Task Force (USPSTF)
Case Western Reserve University researchers and partners, including a collaborator at Cleveland Clinic, are pushing the boundaries of how “smart”
Treating breast tumors with two cancer drugs simultaneously may prevent endocrine resistance by attacking the disease along two separate gene
A breast cancer cell is like a house with three locks on the front door. Keys, or receptors, allow drugs
About one in eight women in the U.S. will develop breast cancer in her lifetime. The vast majority of these
Scientists from Harvard Medical School, in Boston, MA, recently made “unexpected” discovery about estrogenreceptor-positive (ER-positive) breast cancer in a study conducted with
University at Buffalo researchers have developed a new method to more accurately predict tumor growth rates, a crucial statistic used
New research finds an association between the ratio of two estrogen metabolites and the risk of all-cause mortality among women